SØR PHARMA INVEST AS
4848 ARENDAL
Return on Equity
98,31 %
Current Ratio
524
Debt-to-Equity Ratio
0,45
| Key figures (NOK) | 2022 | |
|---|---|---|
| Revenue | 1 000 000 | |
| Net Income | 991 000 | |
| Total Assets | 1 463 000 | |
| Total Equity | 1 008 000 |
| Income (NOK) | 2022 | |
|---|---|---|
| Revenue | 1 000 000 | |
| Expenditure | 7 000 | |
| Operating Profit | 993 000 | |
| Financial Income | 0 | |
| Financial Costs | 0 | |
| Financial Balance | 0 | |
| Earnings Before Tax | 993 000 | |
| Tax | 2 000 | |
| Net Income | 991 000 |
| Balance (NOK) | 2022 | |
|---|---|---|
| Total Fixed Assets | 415 000 | |
| Total Current Assets | 1 048 000 | |
| Total Assets | 1 463 000 | |
| Total Retained Equity | 983 000 | |
| Total Equity | 1 008 000 | |
| Total Long-Term Debt | 453 000 | |
| Total Current Debt | 2 000 | |
| Total Equity and Debt | 1 463 000 |
| Cash flow (NOK) | 2022 | |
|---|---|---|
| Sales Income | 0 | |
| Other Income | 1 000 000 | |
| Revenue | 1 000 000 | |
| Cost of Goods Sold | 0 | |
| Salary Costs | 0 | |
| Depreciation | 0 | |
| Impairment | 0 | |
| Expenditure | 7 000 | |
| Operating Profit | 993 000 | |
| Financial Income | 0 | |
| Financial Costs | 0 | |
| Financial Balance | 0 | |
| Dividends | 0 | |
| Net Income | 991 000 |
| Balance details (NOK) | 2022 | |
|---|---|---|
| Goodwill | 0 | |
| Total Intangible Assets | 0 | |
| Real Eastate | 0 | |
| Machinery and Plant Facilities | 0 | |
| Fixtures | 0 | |
| Total Tangible Assets | 0 | |
| Total Fiancial Fixed Assets | 415 000 | |
| Total Fixed Assets | 415 000 | |
| Stock | 0 | |
| Total Investments | 0 | |
| Cash, Bank | 48 000 | |
| Total Current Assets | 1 048 000 | |
| Total Assets | 1 463 000 | |
| Total Equity | 1 008 000 | |
| Short-Term Group Debt | 0 | |
| Total Long-Term Debt | 453 000 | |
| Creditors | 0 | |
| Unpaid Taxes | 0 | |
| Dividends | 0 | |
| Other Current Debt | 0 | |
| Total Current Debt | 2 000 | |
| Total Equity and Debt | 1 463 000 |
| Financial indicators | 2022 | |
|---|---|---|
| Return on Equity | 98,31 % | |
| Debt-to-Equity Ratio | 0,45 | |
| Operating Profit Margin | 99,3 % | |
| Current Ratio | 524 | |
| Quick Ratio | 524 | |
| Equity Ratio | 0,69 | |
| Gross Profit Margin | 100 % |
Rotate your device to see the full table